59-Year-Old Man Presents With Low Back Pain & Bone Lesion

Poll

A 59-year-old man presents with lower back pain. Diagnostic imaging reveals the presence of a lesion in the bone in the lower back area. A prostate and bone biopsy are performed. What is your diagnosis?

A 59-year-old man presents with lower back pain.  Diagnostic imaging reveals the presence of a lesion in the bone in the lower back area.  A prostate and bone biopsy are performed and results are shown below, respectively.


 

What is your diagnosis?

A. Benign prostatic hyperplasia and metastatic adenocarcinoma of lung to bone
B. Prostatic adenocarcinoma metastatic to bone
C. Prostatic adenocarcinoma and metastatic adenocarcinoma to bone of unknown origin
D. Prostatic adenocarcinoma and bone negative for tumor

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
Related Content
Improving Leukoplakia Follow-Up: Information Leaflets, Habit Cessation Counseling

Improving Leukoplakia Follow-Up: Information Leaflets, Habit Cessation Counseling

Shaila Mulki, PhD, MDS;Seema Mavinapalla, MDS;Supriya Hulimane, MDS;Elizabeth Sojan, MDS;Deviprasad Nooji, MDS;Vidya Gowdappa Doddawad, MDS
September 18th 2025
Article
Experts detailed key advances in myelofibrosis, multiple myeloma, and lymphoma at the Society of Hematologic Oncology 2025 Annual Meeting.

Unraveling Key Blood Cancer Takeaways From the 2025 SOHO Meeting

Francesca Palandri, MD, PhD;Sundar Jagannath, MD;Adam J. Olszewski, MD
September 18th 2025
Podcast
Responses observed with the elranatamab-based regimen in the MagnetisMM-6 trial are anticipated to deepen with longer follow-up.

Elranatamab Combo Yields Early Efficacy in Transplant-Ineligible NDMM

Russ Conroy
September 18th 2025
Article
A group of community and academic oncologists exchanged ideas on optimizing therapy across different prostate, kidney, and bladder cancer populations.

Elevating Community Oncology Care: Insights From World GU 2025

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Sam S. Chang MD, MBA;Jeff Yorio, MD
September 18th 2025
Podcast
Clinical benefit with the investigational agent was reported among 48% of patients with solid tumors at or above the therapeutic dose threshold.

LP-184 Shows Favorable Safety, Pharmacokinetics in Advanced Solid Tumors

Roman Fabbricatore
September 18th 2025
Article
Molecular Characterization of a Rare Glioblastoma Case With Atypical Histopathologic Features

Molecular Characterization of a Rare Glioblastoma Case With Atypical Histopathologic Features

Nanuli Gvazava, MD;Tolga Tuncer, MD;Wei Zhang, MD, PhD;Anup Kasi, MD, MPH;Uma Bhoot
September 18th 2025
Article